Growth Metrics

Usana Health Sciences (USNA) Long-Term Deferred Tax (2016 - 2026)

Usana Health Sciences has reported Long-Term Deferred Tax over the past 16 years, most recently at $25.2 million for Q2 2026.

  • Quarterly Long-Term Deferred Tax rose 33.52% to $25.2 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $25.2 million through Apr 2026, up 33.52% year-over-year, with the annual reading at $27.2 million for FY2026, 38.51% up from the prior year.
  • Long-Term Deferred Tax was $25.2 million for Q2 2026 at Usana Health Sciences, down from $27.2 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $27.2 million in Q1 2026 and troughed at $4.5 million in Q2 2022.
  • The 5-year median for Long-Term Deferred Tax is $15.5 million (2023), against an average of $15.7 million.
  • The largest YoY upside for Long-Term Deferred Tax was 138.23% in 2022 against a maximum downside of 12.04% in 2022.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $9.8 million in 2022, then soared by 35.56% to $13.3 million in 2023, then surged by 47.88% to $19.6 million in 2024, then increased by 22.97% to $24.2 million in 2025, then grew by 4.15% to $25.2 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Long-Term Deferred Tax are $25.2 million (Q2 2026), $27.2 million (Q1 2026), and $24.2 million (Q3 2025).